Tower Research Capital (TRC)’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-2,731
| Closed | -$45K | – | 4424 |
|
|
2017
Q3 | $45K | Buy |
2,731
+1,231
| +82% | +$20K | ﹤0.01% | 2068 |
|
|
2017
Q2 | $27K | Buy |
+1,500
| New | +$28K | ﹤0.01% | 1069 |
|
|
2016
Q3 | – | Sell |
-1,162
| Closed | -$23K | – | 5062 |
|
|
2016
Q2 | $23K | Buy |
1,162
+730
| +169% | +$13.6K | ﹤0.01% | 2143 |
|
|
2016
Q1 | $7K | Sell |
432
-158
| -27% | -$3.24K | ﹤0.01% | 2465 |
|
|
2015
Q4 | $13K | Sell |
590
-7,366
| -93% | -$153K | ﹤0.01% | 1844 |
|
|
2015
Q3 | $135K | Buy |
7,956
+3,037
| +62% | +$47.3K | 0.01% | 426 |
|
|
2015
Q2 | $68K | Sell |
4,919
-1,617
| -25% | -$21.5K | 0.01% | 1131 |
|
|
2015
Q1 | $89K | Buy |
+6,536
| New | +$75.4K | 0.01% | 995 |
|
|
2014
Q4 | – | Sell |
-5,000
| Closed | -$62K | – | 5132 |
|
|
2014
Q3 | $62K | Buy |
5,000
+4,836
| +2,949% | +$67.4K | 0.01% | 1358 |
|
|
2014
Q2 | $2K | Sell |
164
-210
| -56% | -$2.75K | ﹤0.01% | 3531 |
|
|
2014
Q1 | $4K | Sell |
374
-240
| -39% | -$2.75K | ﹤0.01% | 3517 |
|
|
2013
Q4 | $7K | Sell |
614
-333
| -35% | -$3.91K | ﹤0.01% | 3345 |
|
|
2013
Q3 | $10K | Buy |
947
+8
| +0.9% | +$75 | ﹤0.01% | 3235 |
|
|
2013
Q2 | $8K | Buy |
+939
| New | +$9.46K | ﹤0.01% | 2620 |
|
Tower Research Capital (TRC)'s OME Position: Q4 2017 in Review
Tower Research Capital (TRC) sold out of Omega Protein (OME) in Q4 2017, closing a stake of 2,731 shares — an estimated $45K sold.
Tower Research Capital (TRC) first reported a position in OME in Q2 2013 and held it in 14 quarters. The position peaked at $135K in Q3 2015. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Tower Research Capital (TRC) reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Tower Research Capital (TRC) sold 2,731 Omega Protein shares in Q4 2017, an estimated $45K.
- Tower Research Capital (TRC) first reported a position in Omega Protein in Q2 2013 and held it in 14 quarters.
- Tower Research Capital (TRC)'s Omega Protein position peaked at $135K in Q3 2015.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.